RSS

EAMS

Santhera Pharmaceuticals has announced that the MHRA has granted a positive scientific opinion through the Early Access to Medicines Scheme (EAMS) to Raxone (idebenone) for patients with respiratory function decline not taking glucocorticoids in DMD more

News

Heart failure medicine LCZ696 (sacubitril valsartan) will be available to the NHS under the Early Access to Medicines Scheme (EAMS) more

News